Role of LDL and Triglycerides in Hyperlipidemia in Diabetes Mellitus

Diabetes mellitus (DM) is one of the diseases affecting people worldwide, regardless of region, race, blood type, and many more. So, the management of DM has been a challenging issue all over. Hyperlipidemia or Dyslipidemia is one of the main root causes of DM, leading to severe cardiovascular diseases. Behavioral therapies like diet and exercise can improve diabetic Dyslipidemia; however, most patients require drug therapy to meet treatment objectives. Statins, fibrates, niacin, and thiazolidinediones are a few drug families that can treat the abnormal lipid and lipoprotein levels linked to insulin resistance and type 2 diabetes. Since, Type I DM is an autoimmune disorder with no significant relationship with the levels of lipoproteins. This current paper focuses on patients with elevated levels of lipoproteins in DM-2.